Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Mark Cuban defends his disruption status
Becker's Healthcare December 4, 2024
Experts in healthcare and the pharmaceutical industry have questioned Mark Cuban’s ability to puncture high-priced medicines. In a 90-minute fireside chat with one of his critics, Mr. Cuban said his company has “truly changed the game.”
Of the 2,200 medications Mark Cuban Cost Plus Drug Co. sells at a discounted price, about a dozen are branded — but brand-name drugs account for a majority of consumer costs.
Architect of the ACA and UPenn professor, Ezekiel Emanuel, MD, PhD, said the company would mitigate shortages but, with its small pool of branded medicines, generate minor cost reductions. Dr. Emanuel wrote the argument in a July STAT opinion piece.
The two recently met at a UPenn event to discuss pharmacy...
Today's Sponsors
Today's Sponsor